Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism

scientific article published on 01 February 1997

Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0041-1345(96)00553-2
P698PubMed publication ID9123275

P50authorCamillo RicordiQ37383548
Jay S SkylerQ64537724
P2093author name stringD Roth
J Miller
G Selvaggi
A Tzakis
G Ciancio
T Karatzas
G W Burke
R Alejandro
T Qian
M Markou
R Cirocco
M Carreno
P2860cites workChimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantationQ34191376
Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantationQ34232532
Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liverQ34406804
Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cellQ71142561
Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection in a rat modelQ71379972
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectkidney transplantationQ740909
P304page(s)1207-1208
P577publication date1997-02-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleDonor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism
P478volume29

Reverse relations

cites work (P2860)
Q37282011A randomized pilot study of donor stem cell infusion in living-related kidney transplant recipients receiving alemtuzumab
Q35087645Alternatives to immunosuppressive drugs in human islet transplantation
Q33742259Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes
Q74414600Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression
Q35893653Donor bone marrow transplantation: chimerism and tolerance
Q47939631Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years
Q74414646Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients
Q37958357How reconstructive transplantation is different from organ transplantation--and how it is not.
Q37811391Immunologic Aspects and Rejection in Solid Organ Versus Reconstructive Transplantation
Q33863187Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state.
Q35877027Mixed chimerism and split tolerance: mechanisms and clinical correlations
Q38228330The applications of bone marrow-derived stem cells to induce tolerance and chimerism in organ transplantation
Q47939667Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction

Search more.